Clinical Trials
Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Sunday, May 4, 2025 12:00 AM
Conditions: Advanced Leiomyosarcoma; Adipocytic Sarcoma; Advanced Liposarcoma Interventions: Drug: Zanzalintinib; Drug: Eribulin Sponsors: Washington University School of Medicine; Exelixis Not yet recruiting
Buprenorphine as a Post-operative Analgesic in Opioid-Naive Patients After Ankle Fracture Surgery
Tuesday, April 29, 2025 12:00 AM
Conditions: Pain, Postoperative; Ankle Fracture Surgery; Opioid Use Disorder; Opioid Dependence; Opioid Analgesia Interventions: Drug: Buprenorphine Transdermal System; Drug: Placebo Patch Sponsors: Jenna-Leigh Wilson; The Foundation for ...
Sunday, April 27, 2025 12:00 AM
Conditions: Social Isolation in Older Adults; Quality of Life (QOL); Activities of Daily Living Interventions: Behavioral: Virtual Senior Center - GrandPad; Behavioral: Virtual Senior Center - No GrandPad Sponsors: Washington University ...
Tuesday, May 6, 2025 12:00 AM
Conditions: Sickle Cell Disease Interventions: Other: mHealth app + booklets Sponsors: Ohio State University; University of Illinois at Chicago; Washington University School of Medicine; Vanderbilt University Medical Center Not yet recruiting
Heart Failure With Reduced Ejection Fraction Polypill Implementation Strategy in Sri Lanka
Thursday, May 8, 2025 12:00 AM
Conditions: Heart Failure With Reduced Ejection Fraction Interventions: Drug: HFrEF Polypill; Other: Comparator Arm Sponsors: Washington University School of Medicine; The George Institute for Global Health, India; RemediumOne; Centre ...
Nasal Obstruction With Oxymetazoline and Corticosteroids
Thursday, May 1, 2025 12:00 AM
Conditions: Nasal Obstruction Interventions: Drug: Oxymetazoline Nasal Spray; Drug: Budesonide nasal spray Sponsors: Washington University School of Medicine Recruiting
Implement and Test Visual Consent Template and Process
Sunday, May 4, 2025 12:00 AM
Conditions: Cancer; Alzheimer Disease Interventions: Other: Visual consent; Other: Standard consent Sponsors: Washington University School of Medicine; Agency for Healthcare Research and Quality (AHRQ) Recruiting
Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
Friday, April 25, 2025 12:00 AM
Conditions: Uterine Cancer; Endometrial Cancer Interventions: Drug: Zanzalintinib; Drug: Paclitaxel Sponsors: Washington University School of Medicine; National Cancer Institute (NCI); Exelixis Not yet recruiting
